Extrawell Pharmaceutical Holdings Ltd. is an investment company, which engages in the marketing and distribution of pharmaceutical products. It operates through the following segments: Manufacturing, Trading, and Gene Development. The Manufacturing segment includes the development, manufacture, and sale of pharmaceutical products. The Trading segment covers the marketing and distribution of imported pharmaceutical products. The Gene Development segment focuses on the commercial exploitation and development of genome-related technology. The company was founded on December 8, 1998 and is headquartered in Hong Kong.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company